UK markets closed

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.52-0.02 (-0.26%)
As of 02:07PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
39,545
298,172
89,959
81,467
Other short-term investments
62,881
29,312
83,506
211,474
Total cash
102,426
327,484
173,465
292,941
Net receivables
17,474
16,785
14,065
15,868
Other current assets
11,603
7,682
8,561
10,359
Total current assets
133,541
353,464
249,870
393,341
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
66,937
84,837
91,839
105,490
Accumulated depreciation
-21,582
-32,836
-38,492
-45,808
Net property, plant and equipment
45,355
52,001
53,347
59,682
Equity and other investments
-
0
67,537
12,750
Other long-term assets
203,103
201,935
4,065
3,284
Total non-current assets
248,458
253,936
124,949
75,716
Total assets
381,999
607,400
374,819
469,057
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
16,940
19,334
Accounts payable
1,524
1,554
3,098
6,775
Accrued liabilities
12,830
20,408
37,948
76,072
Deferred revenues
-
24
98
11,523
Total current liabilities
24,767
28,715
58,587
123,571
Non-current liabilities
Long-term debt
-
-
599,394
599,836
Deferred revenues
0
192
310
348
Other long-term liabilities
33,707
27,095
2,180
1,833
Total non-current liabilities
144,237
136,885
654,805
649,237
Total liabilities
169,004
165,600
713,392
772,808
Stockholders' equity
Common stock
0
1
1
1
Retained earnings
-909,104
-853,911
-1,726,043
-1,526,617
Accumulated other comprehensive income
-65
-15
0
47
Total stockholders' equity
212,995
441,800
-338,573
-303,751
Total liabilities and stockholders' equity
381,999
607,400
374,819
469,057